WATSON 3359 WATSON 3359 (Tacrolimus 5 mg)

Pill imprint WATSON 3359 WATSON 3359 has been identified as Tacrolimus 5 mg.

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 3359 WATSON 3359

Tacrolimus 5 mg WATSON 3359 WATSON 3359
Tacrolimus
Imprint:
WATSON 3359
WATSON 3359
Strength:
5 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcineurin inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-3359
Inactive Ingredients:
lactose anhydrous
croscarmellose sodium
hypromelloses
magnesium stearate
gelatin
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
FD&C Red No. 40

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)